Clinically proven results

QAL-100™ the active complex in the SKIN.NY® Radical cosmetic range has undergone extensive research and studies which prove it’s effectiveness in reducing wrinkles and improving facial complexion.

The research work and findings have been published by the peer review journal, The British Journal of Dermatology (BJD). The British Journal of Dermatology publishes papers on all aspects of the biology and pathology of the skin and is regarded as the most prestigious source of research information for professional Dermatologists worldwide. When the BJD published the clinical trial on SKIN.NY® with QAL-100™ it was the first time since it’s inception in 1888 that the BJD has published research on a cosmetic cream.

The cosmetic and beauty market has, through the years, been characterized by an immense choice of products and substances, most of which promise a positive effect against age associated skin problems but, seldom deliver results. Prior to QAL-100™ only creams containing retinoic acid have a proven physiological effect. Unfortunately, retinoic acid causes strong adverse effects for most users.

The clinical studies were conducted by Professor Beitner at the prestigious Karolinska University Hospital in Sweden, home of the Nobel prize for medicine. The studies, which consisted of four separate methods of evaluation, demonstrated that SKIN.NY® with QAL-100™ contains skin revitalising qualities similar to those found in retinoic acid but with the conclusive difference that no adverse effects were noted.

The duration of the clinical trial was twelve weeks. Two coded tubes, marked right and left but otherwise identical, were given to the test subjects. The contents of one tube, a cream base (placebo cream), was applied to one half of the face. The contents of the other tube containing SKIN.NY® with QAL-100™, was applied to the other half of the face. Neither the test supervisor nor the test subjects knew which tube contained SKIN.NY® with QAL-100™.

Four test methods were employed:

1. Self evaluation
2. Laser profilometry
3. Clinical evaluation
4. Photographic evaluation

In the self evaluation the test subjects evaluated the effect according to the same criteria employed by the test supervisor in the clinical evaluation.

The structure of the skin (above all, the depth of the wrinkles) was measured objectively using laser profilometry. A silicon imprint of the same area of skin was made at the start of the test and at the end of the test. Imprints were taken from the area around the side of the eyes to a fixed point at the ears on both sides of the face. A powerful laser measured the distance between a number of points on the imprints and then compared them. Such detailed analyses allowed a completely objective comparison. Considerable improvement was shown in all test subjects.

The test supervisor evaluated the appearance of the skin, using a scale of nine and according to the aforementioned criteria, at the start of the test period, on four separate occasions during the test period and at the end of the test period, that is, after twelve weeks.

In the photographic evaluation the effect was evaluated according to the first five criteria used in the clinical evaluation. All photography was completed by a Swedish photographer who specialised in skin photography. The same equipment, lighting and location was used at the beginning of the test and at the end of the test. The photographs were examined by the test supervisor using highly advanced magnifying equipment.

The first three evaluation methods employed in the clinical study provided very positive treatment results. These results were confirmed by the fourth evaluation method (laser profilometry) which showed a 51% reduction of eye wrinkles after three month's usage. Given these results it can be confirmed that SKIN.NYT with QAL-100T is a breakthrough in obtaining a truly effective method of treatment and prevention of age-related skin problems.